Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

NCT02864849 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
RADIATION: Intensity modulated radiotherapy
PROCEDURE: Total mesorectal excision

Sponsor

Peking University Cancer Hospital & Institute